Back to Results

Item 9 Labs Corp (INLB)

Item 9 Labs Corp. is a common stock listing on OTC Markets for a U.S.-based company focused on the cannabis sector. The business operates as a vertically integrated cannabis operator and dispensary franchisor, with activities organized across Cultivation, Franchising, and Corporate segments. It produces cannabis and cannabis-related products including flower, concentrates, distillates, and hardware, and sells cannabis and cannabis-derived products and technologies through licensed dispensaries in Arizona. The company also develops and operates medical and adult-use dispensary franchises under the Unity Rd brand. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Market Cap
OTC-INLB	Not available	Not available	Not available	Fair	0.0%	December 2, 2026	0.701 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Pharmaceuticals

Quality & Risk

Financial Health

Fair

Upcoming Events

Next Earnings Date

December 2, 2026

Days to Earnings

Valuation • Fair Value

Item 9 Labs Corp (OTC-INLB) Fair Value by Valuation Model

No usable valuation estimate is currently available for Item 9 Labs Corp (OTC-INLB); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Item 9 Labs Corp (OTC-INLB). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Item 9 Labs Corp (OTC-INLB)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Item 9 Labs Corp (OTC-INLB) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Item 9 Labs Corp (OTC-INLB)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Item 9 Labs Corp (OTC-INLB). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Item 9 Labs Corp (OTC-INLB)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 2, 2026

Days to Earnings

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Item 9 Labs Corp (OTC-INLB), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Item 9 Labs Corp (OTC-INLB) Stock Forecast & Technical Outlook

Review Item 9 Labs Corp (OTC-INLB) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Sell

The daily technical read for Item 9 Labs Corp (OTC-INLB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Sell

The weekly technical read for Item 9 Labs Corp (OTC-INLB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Strong Sell

The monthly technical read for Item 9 Labs Corp (OTC-INLB) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Item 9 Labs Corp (OTC-INLB)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy

Consolidated analyst recommendation mix

Hold

Based on the available recommendation mix, Item 9 Labs Corp (OTC-INLB) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0

Hold 1

Sell 0

FAQ • Fast Investor Answers

Item 9 Labs Corp (OTC-INLB) Stock FAQ

Data-supported answers about Item 9 Labs Corp (OTC-INLB), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

Financial Health

Fair

Current financial-health read

A reliable fair value estimate is not currently available for Item 9 Labs Corp (OTC-INLB). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Item 9 Labs Corp (OTC-INLB) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Item 9 Labs Corp (OTC-INLB) is December 2, 2026.

The latest available data indicates no current dividend yield for Item 9 Labs Corp (OTC-INLB).

The current market capitalization listed for Item 9 Labs Corp is 0.701 K.

The ticker symbol for Item 9 Labs Corp is OTC-INLB, and the stock is listed on OTC Markets.

Item 9 Labs Corp (OTC-INLB) is listed on OTC Markets.